Chemistry: analytical and immunological testing – Biospecific ligand binding assay
Patent
1981-11-16
1984-01-03
Padgett, Benjamin R.
Chemistry: analytical and immunological testing
Biospecific ligand binding assay
436504, 436 64, 436 63, 436 86, 436813, 424177, 424 11, 260112R, 435 23, 435 18, 435 4, 435 68, G01N 3316
Patent
active
044242786
ABSTRACT:
A method of detecting cancer in mammals which comprises admixing with a serum sample from said mammal detectably labelled acyl carrier protein and subsequently determining the amount of B-protein-acyl carrier protein complex which is formed.
REFERENCES:
patent: 4160817 (1979-07-01), Bucovaz et al.
patent: 4234476 (1980-11-01), Bucovaz et al.
patent: 4261967 (1981-04-01), Bucovaz et al.
patent: 4368262 (1983-01-01), Bucovaz et al.
Bucovaz, E. T. et al., Federation Proceedings, vol. 41, No. 3, abstract 341, (1982).
Bucovaz Edsel T.
Whybrew Walter D.
Moskowitz M.
Padgett Benjamin R.
Research Corporation
LandOfFree
Cancer detection procedure using an acyl carrier protein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cancer detection procedure using an acyl carrier protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cancer detection procedure using an acyl carrier protein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1032208